Switch to the original Schedule Online view

Community Schedule

Enter at least 4 characters

0 matches for: 'molnupiravir' in the Therapeutic Groups

1 results showing for: 'molnupiravir'

[Xpharm]
- No patient co-payment payable
- Subsidy by endorsement
  • Cap 200 mg
    • Brand Fully subsidised brand. Lagevrio
    • Pharmacode2635224
    • Subsidy $0.00
    • Measure / Qty per 40

Treatment is funded only if patient meets access criteria for oral antiviral COVID-19 treatments (as on Pharmac’s website) and has been endorsed accordingly by the prescriber. The supply of treatment is via Pharmac’s approved distribution process. Refer to the Pharmac website for more information about this and stock availability.

For eye preparations refer to Eye Preparations, Anti-Infective Preparations, page 236

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • B Bolded Pharmacode means that the product is to be delisted soon
  • Sole Subsidised Supply